| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d51a565e0a6d7bd7d971f80f3dae0441 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02P20-55
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A63B2102-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-323
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A63B2102-16 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-113
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A63B59-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H19-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H21-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H19-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H19-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H19-06 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H19-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H21-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-113
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D211-42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H19-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H19-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H19-10 |
| filingDate |
2000-07-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6bc927736022c4856f040a733e5237a2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3bbe2134c4869ae1a4d975730c31b7ed
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_61a1b475ecafecbe6d3fecbeefd76028
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cb5d4156744886681fe6f30ba22e3e0f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d40ecbec6686abeda7cd6cde3c34f642 |
| publicationDate |
2002-03-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-20020022734-A |
| titleOfInvention |
Nucleotide monomer containing six-membered azasugar and antisense oligomers thereof |
| abstract |
The present invention relates to antisense monomers and oligomers capable of inhibiting transcription in producing disease-causing proteins. The antisense monomers and oligomers of the present invention are superior to those of DNA, which are intended for general antisense drugs, to RNA. In addition, cell membrane permeability can be improved by exhibiting nuclease resistance.n n n The monomers and oligomers of the present invention can be usefully used for inhibiting the expression of genes causing disease and for hybridization of reagents for gene cloning and diagnostics. The compounds can also be used for protein analysis. |
| priorityDate |
1999-07-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |